Clinical Trial Update: Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease [NA]

View source ↗

Summary

A clinical trial investigating the use of magnetic resonance spectroscopy with MRI to determine the extent of breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer | NA | Status: WITHDRAWN